Wi-Fi Securities Limited is a cyber security company that aims to revolutionise the security of public access Wi-Fi. To realise this vision, the company is developing a unique patent-protected system called SpriteGuard™ which will protect you and your data from hackers by stopping you connecting to fake hotspots. The system is targeted towards the $550 bn worldwide hospitality industry and has the ability to expand to other large global markets like city-wide free Wi-Fi, airports and coffee shops. Moreover, Wi-Fi Securities Limited has a highly experienced Wi-Fi Securities management board that has a track record of delivering multi-million-pound projects from concept to successful commercial deployment.
days to go:
Extended
investment:
£1,014,708
miiCARE is a MedTech specialising in AI applied to geriatrics (elderly care). Its key product miiCUBE offers cutting-edge home-based and customised healthcare, helping the elderly enjoy their independence while being comprehensively connected to their families, friends, and neighbours. The company aims to provide these benefits to one billion people by 2028, comprising older people, family members and carers. Till date, miiCARE has secured partnerships with the UK’s largest NHS trust, Ebbsfleet Garden City, O2, Bristol Careline and Microsoft, and won multiple social impacts and digital health awards during the last 12 months. Funds raised will be used mainly for fulfilling pre-orders and close interests for large contracts with corporates, marketing and logistics, product development, sales and salaries.
days to go:
Expired
investment:
£103,672
Emission Solutions (EMSOL) empowers organisations to take everyday steps to reduce emissions through their real-time emission monitoring and analytics system. EMSOL's open framework platform is built with networks of sensors like air and noise pollution, vehicle tracking, and working with any asset tags and emission sensors which enables EMSOL to perform real-time measurements with location tags and calibrated sensors. Data from these platforms are easily shared on dashboards, through notifications and gives detailed real-time data on urban noise, air quality, and vehicle pollution. To date, EMSOL won Rushlight Environmental Analysis Award, achieve yearly income targets, rated 5th place in the national PowerUp Index and 4th in the London and South East region. Moreover, EMSOL also won a fully funded project sponsored by DFT to deploy EMSOL technology into the rail sector. The company will use the funds to expand its customer base and increase the number of deployment sites.
days to go:
Expired
investment:
£316,884
The Pension Lab offers an interative platform for employees and individuals, helping them reconnect and engage with their pensions. Its mission is to provide the customers with better knowledge of pensions and promote long-term financial decision making. The company has reached the finals of 'Pitchfest' competition held at the NEC as a component of “Venturefest”, and it is also a finalist in the “Innovation in Business” category. Some of the best Fintech solutions providers and pension services such as Yodlee and Origo are in partnership with the Pension Lab. With the proceeds, the company will develop its working capital, infrastructure development, and customer acquisition.
days to go:
Expired
investment:
£38,024
Supermeal is an online food ordering platform offering instant cashback to the customer for every order they place. Supermeal has served more than 50k orders and listed over 100k food items on its portal. The company is signing up 45+ restaurant partners every month with a total of registered 675+ restaurant partners. Supermeal has followed a business model that reduces the fees restaurants pay to 7% and provides a mandatory cashback (5%) to consumers. It has given £11,000+ in cashback and attracted over 10,000 customers generating £53k in device sales and £220,000 in orders. With the proceeds, the company will accelerate its marketing efforts, strengthen its senior management, and operational activities.
days to go:
Expired
investment:
£575,000
Perfectly Spoken offers English learning courses online for free in response to the global demand for learning the English language. The user base of this company has grown exponentially to 125,000+ users in less than a year and forecasted to grow at the rate of 30,000+ new users in a month. Perfectly Spoken has grown to 65,000 active followers on social media and is likely to attract book subscriptions from companies and higher education institutions. The additional revenue streams on the consideration include advertising and sponsorship, licensing of content, potential joint ventures, white labeling and develop parallel language services starting with Spanish.
days to go:
Expired
investment:
£60,750
Paysme is a fintech company that has the vision to become the entrusted supplier of digital financial services to SME communities, by gathering mobile payments, pensions, banking, insurance, e-commerce, marketing tools and accounting in the sector-focused application. Paysme has a marketing partnership with two major credit card corporates. Paysme's expert industry application includes Marketti for market traders, cab: app for taxis & Fanslive for sports clubs. The company has processed over 1.4 million mobile payment transactions and onboarded 200+ markets to its Marketti platform. Also, the company is in discussions with 3 major sports clubs (2 football and 1 rugby) in England, Ireland, and Scotland.
days to go:
Expired
investment:
£102,850
RightIndem is a white-label insurance software platform designed to deliver fast claims to claimants on its portal. The company develops and sells its own proprietary cloud-based digital claim process management software ‘as a service’ to the global insurance market. Insurtech is a vast market and attracts large amounts of investment, with $4.36 billion invested in the first three quarters of 2019. Till date, it has contracted clients such as Axa XL, Archipelago, NN Belgium, NN Netherlands, and Mapfre, with engagements at various levels of implementation and progress in the UK, Italy, Peru, US, and South Africa. They have also earned regard for automating claims processes form some of the world’s largest insurance organizations allowing for the settlement of low to mid-value claims within hours instead of days or months. With the proceeds, the company will connect operating expenses to the point where client revenues from claim volumes match operating costs.
days to go:
Expired
investment:
£200,001
Cuckoo is an internet broadband provider. The company claims that incumbent internet providers treat customers with poor customer service, high prices, and complicated contracts. Cuckoo aims to change this by providing users with fair and transparent prices, simple contracts, high-quality routers, and responsive customer service. The company is currently developing its website and billing engine ahead of launching with its first customers in the second quarter of 2020. Cuckoo's business is in the pre-revenue stage. It expects to start generating revenue in May/June 2020 when they launch their broadband service. Cuckoo will use 50% of the investment towards paying salaries to staff, 25% as technology development fees, 10% as professional fees, 5% as rent, and 10% as AOB. Cuckoo's exit strategy is via a trade sale or listing in the United Kingdom.
days to go:
Expired
investment:
£69,622
Accunea is the world’s first real-time continuous organ function monitoring company, specializing in biomarkers for kidney transplantation. Targeting NHS hospitals in the UK undertaking renal transplantation, the company aims to provide relief to patients awaiting organ transplants by ensuring availability of more organs for transplant and reducing the numbers of deaths due to increasing waiting list times. For this purpose, the company has designed a miniature analysis device which constantly monitors markers of kidney function and metabolism through a standard dribble line put into the vein of a patient. Accunea is raising £400,000 at a pre-money valuation of £2,230,000. The funds will be used to achieve clinical utility in Kidney and Pancreas.
days to go:
Expired
investment:
£388,038
